SUN — Surgical Innovations Income Statement
0.000.00%
Last trade - 00:00- £6.53m
- £7.57m
- £11.95m
- 19
- 59
- 83
- 53
Annual income statement for Surgical Innovations, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 6.33 | 9.13 | 11.3 | 12 | 11.9 |
| Cost of Revenue | |||||
| Gross Profit | 1.27 | 3.13 | 3.92 | 3.45 | 3.44 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 9.5 | 9.58 | 11.3 | 12.6 | 13.9 |
| Operating Profit | -3.17 | -0.455 | 0.041 | -0.596 | -1.95 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -3.31 | -0.585 | -0.057 | -0.728 | -2.05 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -3.28 | -0.456 | 0.264 | -0.509 | -1.94 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -3.28 | -0.456 | 0.264 | -0.509 | -1.94 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -3.28 | -0.456 | 0.264 | -0.509 | -1.94 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.003 | -0 | 0 | -0.001 | -0 |